Elutia (ELUT) Cash from Operations Growth (1y) (2020 - 2026)
Elutia (ELUT) Cash from Operations Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.08 Bn | 175.79 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 128.71 Bn | 125.83 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 108.79 Bn | 99.57 Bn | 6.41 Bn | 1.78% |
| 4 | Boston Scientific | 68.41 Bn | 66.96 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 48.34 Bn | 44.67 Bn | 1.29 Bn | -84.38% |
| 6 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | 16.00% |
| 7 | Dexcom | 28.34 Bn | 27.22 Bn | 750.30 Mn | 185.96% |
| 8 | Smith & Nephew | 26.87 Bn | 26.29 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 122.43% |
| 10 | Elutia | 39.14 Mn | 10.65 Mn | 1.80 Mn | 12.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.17% |
| Dec 31, 2025 | -102.41% |
| Sep 30, 2025 | 15.38% |
| Jun 30, 2025 | -89.73% |
| Mar 31, 2025 | -236.27% |
| Dec 31, 2024 | -34.94% |
| Sep 30, 2024 | 33.11% |
| Jun 30, 2024 | -81.33% |
| Mar 31, 2024 | 48.88% |
| Dec 31, 2023 | -73.17% |
| Sep 30, 2023 | 7.11% |
| Jun 30, 2023 | 77.67% |
| Mar 31, 2023 | 29.71% |
| Dec 31, 2022 | 17.88% |
| Sep 30, 2022 | -78.02% |
| Jun 30, 2022 | -1,259.59% |
| Mar 31, 2022 | -42.06% |
| Dec 31, 2021 | -18.98% |
| Sep 30, 2021 | -152.07% |
| Jun 30, 2021 | 80.28% |